PTC

Analyst Note: PTC Inc. (PTC)

Date: 2026-06-20 Event Date: 2026-06-20

1. Structural Readiness

• Conservative Entry: None (Setup invalidated).
• Aggressive Entry: $155.22 (Pre-breakout/Formation entry is no longer valid as the structure has broken).
• Breakout Level: $219.69 (Resistance level previously identified; no longer actionable as the base has collapsed).
• Current Price: $114.75.
• Extension: — (No extension calculation applicable as the setup is invalid).
• ATR Context: Current ATR is 4.8% (High volatility bucket).

2. Thesis Layer

Thesis Status: Tactical / Setup-Led Secular Thesis: None named at this date.

This is a TACTICAL, setup-led name. There is no named macro or secular thesis attached to this specific setup at the time of analysis. The investment case must be judged strictly on the quality of the technical setup (which is currently failed) and the underlying business fundamentals. No external narrative or macro theme should be invented to justify holding a position in a technically invalidated structure.

3. Business Overview

Company: PTC Inc. Industry: Technology / Software (Industrial & Enterprise) Business Model: Subscription-based software with high recurring revenue.

As of June 2026, PTC operates as a provider of Product Lifecycle Management (PLM) and Industrial Internet of Things (IIoT) software. The company has recently executed a significant strategic pivot by divesting non-core assets to focus on its core platform.

• Core Revenue & Growth: In Q2 2026 (ended May 2026), PTC reported constant currency ARR (excluding the divested Kepware and ThingWorx businesses) of $2.388 billion, representing an 8.5% year-over-year increase at the high end of guidance. Management expects fiscal '26 constant currency ARR growth (excluding divested units) to be between 7.5% and 9.5%. For Q3 2026, they expect growth of 8% to 9%, corresponding to net new ARR of $40 million to $55 million.
• Strategic Divestiture: On March 13, 2026, PTC sold its Kepware and ThingWorx businesses to an entity affiliated with TPG Global. The total consideration was $530.8 million, with $523.3 million received in cash during Q2 2026. An additional contingent consideration of up to $125 million is possible based on future events. This transaction was intended to streamline the portfolio.
• Cash Flow: Management expects to generate $850 million in free cash flow for fiscal '26. They noted that this figure includes $100 million in non-recurring items (net impact), establishing a $950 million baseline for fiscal '27 modeling.
• Customer Base & Verticals: Approximately 95% of 2025 revenue is recurring. The customer base spans Industrials, Federal/Aerospace/Defense, Electronics/High Tech, Automotive, and Medical Technology. 75% of sales are direct to end-users.
• AI Strategy: Management is scaling AI capabilities, noting a near-doubling of AI releases in 2026 versus 2025. They emphasize that "product data foundation is the backbone of AI-driven transformation," positioning PTC to capture value as AI agents require trusted data context.

4. Archetype and Conviction

Archetype: Quality Compounder (Source: layer_b) Fit Analysis: PTC fits the Quality Compounder archetype due to its high recurring revenue (95%), strong free cash flow generation ($950M baseline), and strategic focus on high-value PLM data. The recent divestiture of Kepware and ThingWorx was a structural move to sharpen this compounder profile, removing lower-margin or non-core assets to improve the quality of the remaining earnings stream.

Conviction Stack:

• Thesis Strength: Low (Tactical only; no macro tailwind).
• Evidence Quality: High. The financials are robust, with clear ARR growth, strong FCF guidance, and a completed major divestiture.
• Structural Quality: High. The business model is sticky (subscription), and the customer base is deep in critical industrial workflows.
• Rerating Potential: The business fundamentals support a rerating, but the technical structure currently prevents any immediate capital deployment. The "Quality Compounder" narrative is being punished by the technical breakdown, likely due to market rotation or a specific negative reaction to the post-divestiture re-rating.

ATR Context: The current ATR of 4.8% places volatility in the "High" bucket. This suggests significant price movement is possible, but in the context of an invalidated setup, it indicates continued downside pressure or a lack of immediate support.

5. Invalidating/Strengthening Factors & Gaps

Invalidation Factors:

• Fundamental: Any miss on the Q3 ARR growth guidance (8-9%) or a reduction in the fiscal '27 FCF baseline below $950M would challenge the "Quality Compounder" thesis.

Strengthening Factors:

• Fundamental: Successful monetization of the "AI native products" and "AI agents" mentioned in the Q2 transcript, leading to accelerated net new ARR beyond the $55M guidance.

Evidence Gaps:

• Missing Evidence: None. The evidence base is complete regarding the Q2 2026 results, the divestiture details, and the strategic outlook.
• Gap in Setup: The lack of a "confirmed" breakout means there is no structural momentum to support a long entry. The gap is purely technical: the market has not yet validated the fundamental strength with price action.

PRIVATE ANALYST CALL

Judgment: Sell Confidence: high Key risks: Fundamental strength (95% recurring revenue, $950M FCF baseline) is currently being ignored by price action; High ATR (4.8%) suggests continued volatility and potential for further downside before stabilization. Sizing hint: Zero position; capital preservation is the priority until structure is re-established. Expected path: Management expects $850M FCF in FY26 and 8-9% ARR growth in Q3; however, the market is currently pricing in a structural break rather than the fundamental compounder narrative. Expected horizon: Indefinite; the setup requires a new formation cycle, not a reversion to the mean of the current invalidation. Failure mode to watch: A close below $114.75 would confirm a deeper breakdown and invalidate any potential for a quick V-shaped recovery.